Thursday 21 July 2016
Royal College of Obstetricians and Gynaecologists, London
This one-day workshop will include a series of presentations, followed by an open discussion to address the question of the future of biosensors in cancer diagnosis. This technology offers the greatest opportunity for low cost, non-invasive, rapid and accurate diagnosis of cancer at the earlier stages when survival is more likely. Is it feasible? Why isn't it happening?
Invited Speakers:
- Nick Ormiston-Smith (Cancer Research UK)
- Dr. Marc van der Schee (Owlstone Ltd.)
- Dr. Pedro Estrela (University of Bath)
- tba (QuantumDx Ltd.)
- Dr. Wendy Alderton (Abcodia Ltd.)
- Prof. Sam Tothill (Cranfield University)
- Prof. Francesco Michelotti (University of Rome)
- Dr. Michael Brand (Sensor100)
Revised Pricing:
- Academic/Clinical delegates £250 + VAT
- Company delegates £250+VAT
- Student delegates £75 + VAT
Register Now: http://www.sensor100.com/BfCD2016/Conference.html